Traws Pharma announces CEO retirement and interim successor

NEWTOWN, Pa. – Traws Pharma, Inc. (NASDAQ: TRAW), a biopharmaceutical company focusing on antiviral therapies, has announced the retirement of its CEO, Werner Cautreels, PhD, effective at the close of…